Sándor George K, Tuovinen Veikko J, Wolff Jan, Patrikoski Mimmi, Jokinen Jari, Nieminen Elina, Mannerström Bettina, Lappalainen Olli-Pekka, Seppänen Riitta, Miettinen Susanna
Department of Oral and Maxillofacial Surgery, University of Oulu, Oulu, Finland.
J Oral Maxillofac Surg. 2013 May;71(5):938-50. doi: 10.1016/j.joms.2012.11.014. Epub 2013 Feb 1.
Large mandibular resection defects historically have been treated using autogenous bone grafts and reconstruction plates. However, a major drawback of large autogenous bone grafts is donor-site morbidity.
This report describes the replacement of a 10-cm anterior mandibular ameloblastoma resection defect, reproducing the original anatomy of the chin, using a tissue-engineered construct consisting of β-tricalcium phosphate (β-TCP) granules, recombinant human bone morphogenetic protein-2 (BMP-2), and Good Manufacturing Practice-level autologous adipose stem cells (ASCs). Unlike prior reports, 1-step in situ bone formation was used without the need for an ectopic bone-formation step. The reconstructed defect was rehabilitated with a dental implant-supported overdenture. An additive manufactured medical skull model was used preoperatively to guide the prebending of patient-specific hardware, including a reconstruction plate and titanium mesh. A subcutaneous adipose tissue sample was harvested from the anterior abdominal wall of the patient before resection and simultaneous reconstruction of the parasymphysis. ASCs were isolated and expanded ex vivo over the next 3 weeks. The cell surface marker expression profile of ASCs was similar to previously reported results and ASCs were analyzed for osteogenic differentiation potential in vitro. The expanded cells were seeded onto a scaffold consisting of β-TCP and BMP-2 and the cell viability was evaluated. The construct was implanted into the parasymphyseal defect.
Ten months after reconstruction, dental implants were inserted into the grafted site, allowing harvesting of bone cores. Histologic examination and in vitro analysis of cell viability and cell surface markers were performed and prosthodontic rehabilitation was completed.
ASCs in combination with β-TCP and BMP-2 offer a promising construct for the treatment of large, challenging mandibular defects without the need for ectopic bone formation and allowing rehabilitation with dental implants.
从历史上看,大型下颌骨切除缺损一直采用自体骨移植和重建钢板进行治疗。然而,大型自体骨移植的一个主要缺点是供区并发症。
本报告描述了使用一种组织工程构建体来替代10厘米的下颌前部成釉细胞瘤切除缺损,该构建体由β-磷酸三钙(β-TCP)颗粒、重组人骨形态发生蛋白-2(BMP-2)和符合药品生产质量管理规范级别的自体脂肪干细胞(ASC)组成,从而重现下巴的原始解剖结构。与先前的报告不同,采用了一步原位骨形成法,无需异位骨形成步骤。使用牙种植体支持的覆盖义齿对重建的缺损进行修复。术前使用增材制造的医用颅骨模型来指导定制硬件(包括重建钢板和钛网)的预弯曲。在切除并同时重建下颌骨体旁组织之前,从患者的前腹壁采集皮下脂肪组织样本。在接下来的3周内对ASC进行体外分离和扩增。ASC的细胞表面标志物表达谱与先前报道的结果相似,并对其体外成骨分化潜能进行了分析。将扩增后的细胞接种到由β-TCP和BMP-2组成的支架上,并评估细胞活力。将该构建体植入下颌骨体旁缺损处。
重建10个月后,在移植部位植入牙种植体,以便获取骨芯。进行了组织学检查以及细胞活力和细胞表面标志物的体外分析,并完成了口腔修复治疗。
ASC与β-TCP和BMP-2联合使用为治疗大型、具有挑战性的下颌骨缺损提供了一种有前景的构建体,无需异位骨形成,并允许使用牙种植体进行修复。